HomeInsightsStock Comparison

Lactose India Ltd vs Strides Pharma Science Ltd Stock Comparison

Lactose India Ltd vs Strides Pharma Science Ltd Stock Comparison

Last Updated on: Jun 03, 2025

Key Highlights

  • The Latest Trading Price of Lactose (India) Ltd is ₹ 96.58 as of 03 Jun 15:30.
  • The P/E Ratio of Lactose (India) Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Strides Pharma Science Ltd changed from 79.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Lactose (India) Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Strides Pharma Science Ltd changed from ₹ 2888 crore on March 2020 to ₹ 7192 crore on March 2024 . This represents a CAGR of 20.01% over 5 years.
  • The revenue of Lactose (India) Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Strides Pharma Science Ltd for the Mar '25 is ₹ 1205 crore as compare to the Dec '24 revenue of ₹ 1160 crore. This represent the growth of 3.9%.
  • The ebitda of Lactose (India) Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Strides Pharma Science Ltd for the Mar '25 is ₹ 205.56 crore as compare to the Dec '24 ebitda of ₹ 214.45 crore. This represent the decline of -4.15%.
  • The net profit of Lactose (India) Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Strides Pharma Science Ltd changed from ₹ -9.36 crore to ₹ 85.62 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Lactose (India) Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Strides Pharma Science Ltd changed from 104.26 % on March 2020 to 35.08 % on March 2024 . This represents a CAGR of -19.58% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Lactose (India) Ltd

  • Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat.
  • The company is engaged in the manufacturing and trading of pharmaceutical products.
  • They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries.
  • The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee.
  • Further, they engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat.

About Strides Pharma Science Ltd

  • Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bengaluru, India.
  • The Company mainly operates in the regulated markets including key markets of US, Europe, Australia, South Africa.
  • It has presence in the emerging markets largely in Africa where it has a branded business and is a pre qualified supplier to donor-funded programme though their institutional business. The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
  • It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
  • Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

Lactose (India) Ltd News Hub

News

Lactose (India) to conduct board meeting

Lactose (India) will hold a meeting of the Board of Directors of the Company on 30 May 202...

Read more

22 May 2025 14:48

News

Lactose (India) schedules board meeting

Lactose (India) will hold a meeting of the Board of Directors of the Company on 12 Februar...

Read more

07 Feb 2025 16:46

News

Lactose (India) to conduct board meeting

Lactose (India) will hold a meeting of the Board of Directors of the Company on 5 December...

Read more

03 Dec 2024 14:06

News

Lactose (India) to convene EGM

Lactose (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will...

Read more

26 Oct 2024 09:29

News

Lactose (India) to hold board meeting

Lactose (India) will hold a meeting of the Board of Directors of the Company on 23 October...

Read more

21 Oct 2024 10:23

News

Lactose (India) to conduct board meeting

Lactose (India) will hold a meeting of the Board of Directors of the Company on 21 October...

Read more

17 Oct 2024 12:35

Strides Pharma Science Ltd News Hub

News

Board of Strides Pharma Science recommends final dividend

Strides Pharma Science announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:03

News

Strides Pharma Science to announce Quarterly Result

Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 22 ...

Read more

17 May 2025 11:40

News

Strides Pharma's US arm acquires four drugs to bolster portfolio

The portfolio consists of liquids and immediate release solid orals which are in the thera...

Read more

30 Apr 2025 07:51

News

Strides Pharma Science announces incorporation of step-down subsidiary

Arco Lab, a wholly owned subsidiary of Strides Pharma Science has incorporated a new wholl...

Read more

11 Apr 2025 15:34

News

Strides Pharma Science announces acquisition of Singapore-based Amexel

Strides Pharma Global (SPG), a step-down wholly-owned subsidiary of Strides Pharma Science...

Read more

15 Mar 2025 15:45

News

Strides Pharma Science appoints director

Strides Pharma Science has appointed Mukta Arora (DIN: 07225715) as Independent Director o...

Read more

31 Jan 2025 10:49

SWOT Analysis Of Strides Pharma Science Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Lactose (India) Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Strides Pharma Science Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Lactose (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Lactose (India) Ltd and Strides Pharma Science Ltd

Which company has a larger market capitalization, Lactose (India) Ltd or Strides Pharma Science Ltd?

Market cap of Lactose (India) Ltd is 136 Cr while Market cap of Strides Pharma Science Ltd is 7,278 Cr

What are the key factors driving the stock performance of Lactose (India) Ltd and Strides Pharma Science Ltd?

The stock performance of Lactose (India) Ltd and Strides Pharma Science Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lactose (India) Ltd and Strides Pharma Science Ltd?

As of June 3, 2025, the Lactose (India) Ltd stock price is INR ₹96.58. On the other hand, Strides Pharma Science Ltd stock price is INR ₹789.75.

How do dividend payouts of Lactose (India) Ltd and Strides Pharma Science Ltd compare?

To compare the dividend payouts of Lactose (India) Ltd and Strides Pharma Science Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions